DAA2191 |
Clusterin increases with age |
Molecular |
parietal lobe |
Human |
CLU |
22.5% Increase Gene Expression Level |
|
DAA2168 |
Clusterin increases with age |
Molecular |
temporal lobe |
Human |
CLU |
25.9% Increase Gene Expression Level |
|
DAA2180 |
Clusterin increases with age |
Molecular |
hippocampus |
Human |
CLU |
58.9% Increase Gene Expression Level |
|
DAA2179 |
Clusterin increases with age |
Molecular |
hippocampus |
Human |
CLU |
41.7% Increase Gene Expression Level |
|
DAA2178 |
Clusterin increases with age |
Molecular |
hippocampus |
Human |
CLU |
33.1% Increase Gene Expression Level |
|
DAA2304 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
parietal lobe |
Human |
CX3CL1 |
61.0% Decrease Gene Expression Level |
|
DAA2298 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
hippocampus |
Human |
CX3CL1 |
31.6% Decrease Gene Expression Level |
|
DAA2295 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
temporal lobe |
Human |
CX3CL1 |
46.7% Decrease Gene Expression Level |
|
DAA2305 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
parietal lobe |
Human |
CX3CL1 |
56.2% Decrease Gene Expression Level |
|
DAA2308 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
frontal lobe |
Human |
CX3CL1 |
58.0% Decrease Gene Expression Level |
|
DAA2307 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
frontal lobe |
Human |
CX3CL1 |
61.1% Decrease Gene Expression Level |
|
DAA2300 |
chemokine (C-X-C motif) ligand 12 decreases with age |
Molecular |
hippocampus |
Human |
CXCL12 |
30.9% Decrease Gene Expression Level |
|
DAA2301 |
chemokine (C-X-C motif) ligand 16 increases with age |
Molecular |
hippocampus |
Human |
CXCL16 |
100.6% Increase Gene Expression Level |
|
DAA2309 |
chemokine (C-X-C motif) ligand 16 increases with age |
Molecular |
frontal lobe |
Human |
CXCL16 |
44.1% Increase Gene Expression Level |
|
DAA2306 |
chemokine (C-X-C motif) ligand 16 increases with age |
Molecular |
parietal lobe |
Human |
CXCL16 |
78.9% Increase Gene Expression Level |
|
DAA2299 |
chemokine (C-X-C motif) ligand 5 increases with age |
Molecular |
hippocampus |
Human |
CXCL5 |
64.9% Increase Gene Expression Level |
|
DAA1072 |
CYFIP2 A to I mRNA editing decreases |
Molecular |
frontal lobe |
Human |
CYFIP2 |
Increase mRNA Editing |
|
DAA1110 |
Dickkopf-like 1 |
Molecular |
frontal lobe |
Human |
DKKL1 |
Increase DNA Methylation |
|
DAA1112 |
Dickkopf-like 1 |
Molecular |
temporal lobe |
Human |
DKKL1 |
Increase DNA Methylation |
|
DAA1082 |
Dipeptidyl-peptidase 8 |
Molecular |
frontal lobe |
Human |
DPP8 |
Increase DNA Methylation |
|
DAA1084 |
Dipeptidyl-peptidase 8 |
Molecular |
temporal lobe |
Human |
DPP8 |
Increase DNA Methylation |
|
DAA2275 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
Molecular |
hippocampus |
Human |
FCER1G |
222.6% Increase Gene Expression Level |
|
DAA2270 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
Molecular |
temporal lobe |
Human |
FCER1G |
98.1% Increase Gene Expression Level |
|
DAA2289 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
Molecular |
frontal lobe |
Human |
FCER1G |
105.3% Increase Gene Expression Level |
|
DAA2281 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
Molecular |
parietal lobe |
Human |
FCER1G |
187.2% Increase Gene Expression Level |
|